Stratasys Announces Enrollment is Now Open for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Pre-Operative Planning

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Stratasys Announces Enrollment is Now Open for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Pre-Operative Planning

Stratasys Inc. (SSYS) PT Lowered to $24 at Jefferies Following 4Q

March 10, 2017 7:25 AM EST

Jefferies lowered its price target on Stratasys Inc. (NASDAQ: SSYS) to $24.00 (from $25.00) while maintaining a Buy rating. Q4 revenue hit $175.3M, above the Street's $169.3M. EPS totaled $0.15, above Consensus of $0.05, driven chiefly by topline outperformance.

Analyst James Kisner commented, "Stratasys posted... More